摘要
目的:探讨宫内良性占位性病变患者经MyoSure治疗后对其妊娠结局的影响。方法:选取2016年1月至2018年12月期间检查发现患有宫内良性占位病变且有妊娠需求的患者96例,其中宫腔镜下电切术治疗组42例,MyoSure治疗组54例,术后随访6个月至2年,分析两组患者经治疗后对自然流产率、足月分娩率等妊娠结局的影响差异。结果:MyoSure组及电切组术后的自然流产率显著低于术前,MyoSure组及电切组术后的足月分娩率显著高于术前,MyoSure治疗组较宫腔镜下电切术治疗组患者术后的自然流产率下降,足月分娩率升高。结论:MyoSure较宫腔镜电切术能够显著降低宫内良性占位病变患者的自然流产率,显著提高足月分娩率,改善患者的妊娠结局。
Objective: To investigate the effects of intrauterine benign space occupying lesions on pregnancy outcome after treatment with MyoSure. Method: From January 2016 to December 2018, 96 patients who had a need for pregnancy with intrauterine benign space occupying lesion were found in our hospital. There were 42 cases in the TCRM treatment group and 54 cases in the MyoSure treatment group. The patients were followed up for 6 months to 2 years and analyzed the pregnancy outcomes such as spontaneous abortion rate and full-term delivery rate after different treatment. Results: The spontaneous abortion rate of the MyoSure treatment group and the TCRM treatment group was significantly lower than that of the preoperative group. The full-term delivery rate of the MyoSure treatment group and the TCRM treatment group was significantly higher than that of the preoperative group. The MyoSure treatment group was compared with the TCRM treatment group, the postoperative spontaneous abortion rate decreased and the full-term delivery rate increased. Conclusions: Compared with hysteroscopic TCRM, MyoSure can significantly reduce the spontaneous abortion rate of patients with benign lesions in the uterus, significantly improve the rate of full-term delivery and improve the pregnancy outcome of patients.
作者
贺丹
赵霞
HE Dan;ZHAO Xia(Department of Obstetrics and Gynecology,the First Affiliated Hospital of Shihezi University School of Medicine,Xinjiang Shihezi,832008)
出处
《农垦医学》
2019年第4期328-331,共4页
Journal of Nongken Medicine